GS-9876: Ph II started

By Julian Zhu | Apr 11, 2017 | 7:38 PM GMT

Gilead began a double-blind, placebo-controlled, international Phase II trial to evaluate oral 200 mg filgotinib (GLPG0634, GS-6034),

Read the full 173 word article

How to gain access

Continue reading with a
two-week free trial.